BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 34060710)

  • 1. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study.
    Noviello D; Costantino A; Muscatello A; Bandera A; Consonni D; Vecchi M; Basilisco G
    Neurogastroenterol Motil; 2022 Feb; 34(2):e14187. PubMed ID: 34060710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.
    Ghoshal UC; Ghoshal U; Rahman MM; Mathur A; Rai S; Akhter M; Mostafa T; Islam MS; Haque SA; Pandey A; Kibria MG; Ahmed F
    J Gastroenterol Hepatol; 2022 Mar; 37(3):489-498. PubMed ID: 34672022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
    Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
    Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Austhof E; Bell ML; Riddle MS; Catalfamo C; McFadden C; Cooper K; Scallan Walter E; Jacobs E; Pogreba-Brown K
    Epidemiol Infect; 2022 Jul; 150():e136. PubMed ID: 35801302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
    Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
    Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
    Caspersen IH; Magnus P; Trogstad L
    Eur J Epidemiol; 2022 May; 37(5):539-548. PubMed ID: 35211871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Long Coronavirus Disease 2019 Gastrointestinal Symptoms 6 Months After Coronavirus Infection Are Associated With Mental Health Symptoms.
    Blackett JW; Wainberg M; Elkind MSV; Freedberg DE
    Gastroenterology; 2022 Feb; 162(2):648-650.e2. PubMed ID: 34728186
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.
    Bianco MR; Modica DM; Drago GD; Azzolina A; Mattina G; De Natale M; Rossi G; Amata M; Canzoneri G; Manganaro G; Di Gregorio F; Russo R; Pricoco S; Saita V; Allegra E
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):182S-185S. PubMed ID: 33350319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
    Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
    PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study.
    Schettino M; Pellegrini L; Picascia D; Saibeni S; Bezzio C; Bini F; Omazzi BF; Devani M; Arena I; Bongiovanni M; Manes G; Della Corte CMR
    Am J Gastroenterol; 2021 Feb; 116(2):306-310. PubMed ID: 33009054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
    Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
    EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.
    Hawkings MJ; Vaselli NM; Charalampopoulos D; Brierley L; Elliot AJ; Buchan I; Hungerford D
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.
    Elmunzer BJ; Palsson OS; Forbes N; Zakaria A; Davis C; Canakis A; Qayed E; Bick B; Pawa S; Tierney WM; McLeod CG; Taylor J; Patel H; Mendelsohn RB; Bala G; Sloan I; Merchant AA; Smith ZL; Sendzischew Shane MA; Aroniadis OC; Ordiah CO; Ruddy JM; Simren M; Tack J; Drossman D;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1098-1107.e3. PubMed ID: 37995983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis.
    Shehab M; Alrashed F; Shuaibi S; Alajmi D; Barkun A
    BMJ Open Gastroenterol; 2021 Mar; 8(1):. PubMed ID: 33664052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
    Menges D; Ballouz T; Anagnostopoulos A; Aschmann HE; Domenghino A; Fehr JS; Puhan MA
    PLoS One; 2021; 16(7):e0254523. PubMed ID: 34252157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term consequences of COVID-19 in patients with functional bowel disorders, rehabilitation prospective of microbiocenosis-oriented therapy].
    Patsenko MB; Ardatskaya MD; Anuchkin AA; Butorova LI; Gaivoronsky IN; Nugaeva NR; Levin VI; Pavlov AI; Topchiy TB; Tuaeva EM
    Ter Arkh; 2023 Dec; 95(12):1119-1127. PubMed ID: 38785051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
    Karaarslan F; Demircioğlu Güneri F; Kardeş S
    Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.